SCA
WST icon

SAC Capital Advisors’s West Pharmaceutical WST Stock Holding History

SAC Capital Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-15,920
Closed -$701K – 1039
2014
Q1 		$701K Buy
+15,920
New +$749K ﹤0.01% 1070
2013
Q4 		– Sell
-9,364
Closed -$385K – 2005
2013
Q3 		$385K Sell
9,364
-30,648
-77% -$1.17M ﹤0.01% 1267
2013
Q2 		$1.41M Buy
+40,012
New +$1.32M 0.01% 844

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KI
Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SAC Capital Advisors's WST Position: Q2 2014 in Review

SAC Capital Advisors sold out of West Pharmaceutical (WST) in Q2 2014, closing a stake of 15,920 shares — an estimated $701K sold.

SAC Capital Advisors first reported a position in WST in Q2 2013 and held it in 3 quarters. The position peaked at $1.41M in Q2 2013. 222 funds tracked by Wall St. Rank hold WST as of Q2 2014.

  • SAC Capital Advisors reported no remaining West Pharmaceutical position as of Q2 2014 after selling out during the quarter.
  • SAC Capital Advisors sold 15,920 West Pharmaceutical shares in Q2 2014, an estimated $701K.
  • SAC Capital Advisors first reported a position in West Pharmaceutical in Q2 2013 and held it in 3 quarters.
  • SAC Capital Advisors's West Pharmaceutical position peaked at $1.41M in Q2 2013.
  • 222 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2014.

Based on SAC Capital Advisors's 13F filing for Q2 2014.